Kolon TissueGene (950160) closed with a steep decline on the KOSDAQ market on the 16th, drawing intense investor attention to what trajectory the stock will show when trading resumes after the Constitution Day holiday.

According to the Korea Exchange, Kolon TissueGene finished trading at 62,100 won, down 15,800 won (20.28%) from the previous trading day. Notably, the decline widened as the afternoon session progressed, with investor sentiment significantly contracting.

The domestic stock market will be closed on the 17th for Constitution Day. Accordingly, overseas financial market movements over the one-day break have been identified as a key variable that will influence domestic investor sentiment on the next trading day. Specifically, analysts suggest that risk asset appetite in U.S. equities and international oil price volatility could shape the overall tone of domestic biotech stocks.

Over the medium to long term, clinical schedules related to TG-C remain a key variable. Some observers project that future disclosures on this front will be critical factors in determining the stock's direction.

Ultimately, investors are expected to remain on high alert during the Constitution Day holiday, monitoring U.S. market trends and the global biotech sector while watching for supply-demand changes and additional clinical news related to Kolon TissueGene on the next trading day.

[※ Investment decisions are the sole responsibility of the investor, and it is essential to verify relevant disclosures and company fundamentals before investing.]